Shorted
Fisher & Paykel Healthcare logo
FPH

Fisher & Paykel Healthcare

Health Care Equipment & Services

Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of medical devices and systems for respiratory care, acute care, surgery, and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries, focusing on improving patient care and outcomes through innovative healthcare solutions and a commitment to 'Care by Design'.

Short position

short percentage0.05%
reported shorts273.1K
shares on issue588.265M

Fisher & Paykel Healthcare (ASX:FPH) has 0.05% of its shares on issue reported as short positions as of 5 Oct 2026, or about 273,054 shares. Over the past 30 days that figure has fallen 0.08 percentage points, and over 90 days it has fallen 0.12 percentage points. Its highest recorded short interest was 1.28% in June 2018. FPH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Fisher & Paykel Healthcare (FPH) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
25 Sept

Which Forces Now Drive Fisher and Paykel (ASX:FPH) Shares?

Highlights Respiratory device maker joined this week's healthcare bid Upgraded guidance and tariff refunds support the outlook Hospital demand and homecare competition are key swing factors Fisher and Paykel Healthcare (ASX:FPH) joined the defensive rally in healthcare shares this week, rising on Monday alongside larger peers as the New Zealand respiratory device maker continues to trade on the back of upgraded earnings guidance and flagged refunds of US tariffs. This Week's Move Fisher and P...

Continue reading
Kalkine
Neutral
3 Sept

Fisher & Paykel Healthcare Reports Option Expiry for Senior Executives Andrew Somervell and Andrew Niccol

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) has announced the lapse of share options held by two senior executives, Vice President of Products & Technology Andrew Somervell and Chief Operating Officer Andrew Niccol, effective 1 September 2026, through ongoing disclosure filings. Key Highlights Andrew Somervell's option holdings decreased from 85,423 to 64,269 following the expiry of 21,154 options on 1 September 2026. Andrew Niccol's options reduced from 23,056 to 18,345 ...

Continue reading
Kalkine
Neutral
23 Aug

What Is Driving Fisher & Paykel Healthcare (ASX:FPH) Higher?

Highlights Fisher & Paykel Healthcare (ASX:FPH) has moved into record territory following a sustained period of stronger market momentum. Revenue expectations and improving margins have helped strengthen sentiment around the healthcare company. Investors are now watching whether operational momentum can support the stock as it enters a new phase of price discovery. Fisher & Paykel Healthcare (ASX:FPH) has moved firmly onto investor watchlists after its shares reached record territory, ...

Continue reading
Kalkine
Neutral
31 Mar

Fisher & Paykel Healthcare (ASX:FPH) rises as KMD Brands (ASX:KMD) falls

Highlights Health technology segment records upward movement during midday trading activity Consumer durables sector experiences declines amid broader market shifts Performance of Fisher & Paykel Healthcare and KMD Brands reflects sector divergence Sector movements in ASX 100 show health technology gains and consumer durables decline, with Fisher & Paykel Healthcare and KMD Brands reflecting broader market trends. The healthcare and retail sectors remain key components of the broader ...

Continue reading